Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
Archives of Dermatological Research
|
July 5, 2024
Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome
Tess M Lukowiak, Brian Cahn, Faramarz Samie, et al.
Archives of Dermatological Research
|
June 7, 2024
Subcision with and without suction for acne scars: a split-faced, rater-blinded randomized control trial
Victoria J Shi, Melissa S Ma, Eric Koza, et al.
Frontiers in Medicine
|
May 7, 2025
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial
Lucia Masarova, Brandi N Reeves, Firas El Chaer, et al.
Lancet Regional Health. Americas
|
June 17, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)
Brandi N Reeves, Firas El Chaer, Lynda Foltz, et al.
Journal of the American Academy of Dermatology
|
September 17, 2024
Development of an Objective Structured Assessment of Technical Skills for Sclerotherapy
Melissa S Ma, Faraaz S Zafar, Mitchel P Goldman, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
Archives of Dermatological Research
|
July 5, 2024
Developing expert consensus for the use of hedgehog inhibitors in basal cell nevus syndrome
Tess M Lukowiak, Brian Cahn, Faramarz Samie, et al.
Archives of Dermatological Research
|
June 7, 2024
Subcision with and without suction for acne scars: a split-faced, rater-blinded randomized control trial
Victoria J Shi, Melissa S Ma, Eric Koza, et al.
Frontiers in Medicine
|
May 7, 2025
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial
Lucia Masarova, Brandi N Reeves, Firas El Chaer, et al.
Lancet Regional Health. Americas
|
June 17, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET)
Brandi N Reeves, Firas El Chaer, Lynda Foltz, et al.
Journal of the American Academy of Dermatology
|
September 17, 2024
Development of an Objective Structured Assessment of Technical Skills for Sclerotherapy
Melissa S Ma, Faraaz S Zafar, Mitchel P Goldman, et al.
Page
of 5